Abstract:Circadian rhythms are cyclic patterns of physiological, behavioural and molecular events that occur over a 24-h period. They are controlled by the suprachiasmatic nucleus (SCN), the brain’s master pacemaker which governs peripheral clocks and melatonin release. While circadian systems are endogenous, there are external factors that synchronise the SCN to the ambient environment including light/dark cycles, fasting/fed state, temperature and physical activity. Circadian rhythms also provide internal temporal organisation which ensures that any internal changes that take place are centrally coordinated. Melatonin synchronises peripheral clocks to the external time and circadian rhythms are regulated by gene expression to control physiological function. Synchronisation of the circadian system with the external environment is vital for the health and survival of an organism and as circadian rhythms play a pivotal role in regulating GI physiology, disruption may lead to gastrointestinal (GI) dysfunction. Disorders of gut-brain interactions (DGBIs), also known as functional gastrointestinal disorders (FGIDs), are a group of diseases where patients experience reoccurring gastrointestinal symptoms which cannot be explained by obvious structural abnormalities and include functional dyspepsia (FD) and irritable bowel syndrome (IBS). Food timing impacts on the production of melatonin and given the correlation between food intake and symptom onset reported by patients with DGBIs, chronodisruption may be a feature of these conditions. Recent advances in immunology implicate circadian rhythms in the regulation of immune responses, and DGBI patients report fatigue and disordered sleep, suggesting circadian disruption. Further, melatonin treatment has been demonstrated to improve symptom burden in IBS patients, however, the mechanisms underlying this efficacy are unclear. Given the influence of circadian rhythms on gastrointestinal physiology and the immune system, modulation of these rhythms may be a potential therapeutic option for reducing symptom burden in these patients.

Back to Roots: Dysbiosis, Obesity, Metabolic Syndrome, Type 2 Diabetes Mellitus, and Obstructive Sleep Apnea—Is There an Objective Connection? A Narrative Review

Melatonin as a Mediator of the Gut Microbiota-Host Interaction: Implications for Health and Disease

Gut Microbiome Composition and Its Association with Sleep in Major Psychiatric Disorders

Melatonin–Microbiome Two-Sided Interaction in Dysbiosis-Associated Conditions

The Microbiota–Gut–Brain Axis in Metabolic Syndrome and Sleep Disorders: A Systematic Review

Sleep Deprivation and Gut Microbiota Dysbiosis: Current Understandings and Implications

Culprit in Cardiovascular Diseases

Circadian Rhythms, Chrononutrition, Physical Training, and Redox Homeostasis—Molecular Mechanisms in Human Health

Gut microbiota and sleep: Interaction mechanisms and therapeutic prospects

The microbiota-gut-brain axis in sleep disorders

The role of insufficient sleep and circadian misalignment in obesity

Metabolic Consequences of Sleep and Circadian Disorders

The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms

Connecting insufficient sleep and insomnia with metabolic dysfunction

Evaluating the Relationship between Circadian Rhythms and Sleep, Metabolic and Cardiovascular Disorders: Current Clinical Evidence in Human Studies

A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications

Gut microbiota: Candidates for a novel strategy for ameliorating sleep disorders

POST-TRAUMATIC STRESS DISORDER, INSOMNIA, HEART RATE VARIABILITY AND METABOLIC SYNDROME (NARRATIVE REVIEW)

Potential Role for the Gut Microbiota in Modulating Host Circadian Rhythms and Metabolic Health

Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions

You Are What You Eat-The Relationship between Diet, Microbiota, and Metabolic Disorders-A Review